See also this year's filing and all EDGAR filings for this company.
PDF Report 0001416083_2012_Catalent_Pharma_Solutions_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001416083, Catalent Pharma Solutions Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 757,700,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,192,700,000 |
| 2 | PropertyPlantAndEquipmentNet | 721,300,000 |
| 3 | remainder_Assets | 159,500,000 |
| 4 | LiabilitiesCurrent | 385,500,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 288,300,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 1,081,100,000 |
| 11 | remainder_Revenues | 1,531,800,000 |
| 12 | remainder_NetIncome | -212,500,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,831,200,000 |
| 1 | Liabilities | 385,500,000 |
| 2 | Expenses | 1,369,400,000 |
| 3 | Revenues | 1,531,800,000 |
| 4 | StockholdersEquity | 2,445,700,000 |
| 5 | NetIncome | -50,100,000 |
| 6 | ComprehensiveNetIncome | -50,100,000 |
| 7 | BaseVar | 3,165,200,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.28 |
| 9 | EconomicCapitalRatio | 3.88 |
Edgar->Model Mapping
Feature Distribution
